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The herpes simplex virus type 1 (HSV-1) mutant in1814 contains an insertion mutation in the coding sequence for the
virion transactivator protein VP16 and is thus impaired for the activation of immediate early (IE) gene expression. This virus
was modified further by introducing the Moloney murine leukemia virus LTR promoter in place of the upstream sequences
controlling expression of the IE regulatory protein ICP0, to yield mutant in1820. In almost all cell types tested, in1820
initiated infection less efficiently than in1814, behaving as if lacking both VP16 and ICP0 functions, but in BHK cells in1820
was less impaired than in1814. A rescuant of in1820 at the VP16 locus, in1825, also exhibited a host range phenotype,
initiating replication as efficiently as wild-type HSV-1 in BHK cells but inefficiently in other cell types. In1825 was unable
to complement an ICP0 null mutant in restricted cells, demonstrating that the promoter exchange prevented the expression
of ICP0 protein in functionally significant amounts. The novel host range properties of in1820 provided a basis for the
construction of additional viruses conditionally impaired for IE gene expression and assessment of their value as prototype
vectors. Production of an HSV-1 mutant multiply defective in the expression of IE gene products was achieved by introduction
of the temperature-sensitive mutation of HSV-1 tsK, which inactivates the IE transcription activator ICP4 at nonpermissive
temperatures, into in1820 to produce in1820K. This mutant could be propagated effectively in BHK cells at 317 but was
effectively devoid of the major regulators ICP0, ICP4, and VP16 in other cells types at 38.57. Cultures could withstand
infection with 5 PFU of in1820K per cell without detectable cytopathology and could be reseeded to form colonies at
approximately 90% efficiency. A derivative of in1820K containing the Escherichia coli lacZ gene controlled by the human
cytomegalovirus (HCMV) major IE promoter expressed low but detectable levels of b-galactosidase in almost all cells after
infection of cultures at 5 PFU per cell and incubation at 38.57. Cultures infected with 5 PFU per cell of an in1820K derivative
expressing neomycin phosphotransferase (npt) controlled by the HCMV IE promoter were resistant to killing by the antibiotic
G418 for up to 3 days, and cell survival correlated with the retention of functional levels of npt. Mutants based on in1820K
can thus express foreign gene products in virtually all cells in a culture under conditions in which cytotoxicity is eliminated,
demonstrating that progressive reduction of IE gene expression is an important step in the design of HSV-1-derived vectors.
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INTRODUCTION porated into a multiprotein complex at TAATGARAT (R is
a purine nucleotide) sequence elements present in all
Infection of permissive cells with herpes simplex virus IE promoters (Post et al., 1981; Campbell et al., 1984;
type 1 (HSV-1) results in the coordinated expression of Pellett et al., 1985; McKnight et al., 1987; O’Hare and
viral gene products. The five genes usually regarded as Goding, 1988; Preston et al., 1988). In addition to VP16
immediate early (IE) (and also the UL39 gene) are tran- the complex contains the cellular factors Oct-1, which
scribed in the absence of de novo protein synthesis, and binds to TAATGARAT, and HCF, a large protein which is
once IE proteins have been produced the early and late cleaved to a number of smaller products (Gerster and
genes are transcribed and virus replication ensues Roeder, 1988; O’Hare and Goding, 1988; Stern et al., 1989;
(Honess and Roizman, 1974; Everett, 1987). The IE pro- Katan et al., 1990; Kristie and Sharp, 1990; Wilson et al.,
teins ICP4 (Vmw175), ICP0 (Vmw110), and ICP27 1993). A major consequence of these protein– protein
(Vmw63) are important regulators of gene expression, interactions is to bring the C-terminal activating region
although ICP0 is not absolutely required for virus replica- of VP16 into proximity with components of transcription
tion (Preston, 1979b; Dixon and Schaffer, 1980; Everett, preinitiation complexes at the IE gene TATA box and cap
1984; O’Hare and Hayward, 1985; Sacks et al., 1985; Stow sites and hence to stimulate IE transcription (Sadowski
and Stow, 1986; Sacks and Schaffer, 1987; Sandri-Goldin et al., 1988; Triezenberg et al., 1988).
and Mendoza, 1992). The IE genes are activated by the The importance of activation of IE transcription by
tegument protein VP16 (Vmw65 or a-TIF), which is incor- VP16 has been demonstrated by analysis of in1814, an
HSV-1 mutant with a 12-base pair (bp) insertion within
the coding sequences for VP16 (Ace et al., 1989). The1 To whom correspondence and reprint requests should be ad-
dressed. Fax: /44 141 337 2236. E-mail: c.preston@vir.gla.ac.uk. insertion disrupts a domain of VP16 crucial for interaction
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with Oct-1 and HCF (Ace et al., 1988; Greaves and deleted for ICP4, the major transactivator of virus gene
expression. Using this double mutant (named 14DH3),O’Hare, 1990; Hayes and O’Hare, 1993), so that in1814
is impaired for the activation of IE transcription. As a significant cell survival was obtained after infection at
m.o.i. values that should ensure that virtually all cells inconsequence of this impairment, in1814 does not initiate
productive replication efficiently after infection of tissue a culture were infected. More recently, Wu et al. have
shown that tissue culture cells survive infection with mu-culture cells under conditions in which only one virus
particle enters a cell; instead, the majority of cells in- tant d95, which is deleted for the IE genes encoding
ICP4, ICP22, and ICP27, for at least 3 days (Wu et al.,fected with in1814 at low m.o.i. retain the viral genome
in a quiescent ‘‘latent’’ state, from which gene expression 1996). Cells infected with d95 did not divide, however,
and could not form colonies after subculture and reseed-cannot be detected (Harris and Preston, 1991). An appar-
ently similar phenotype is observed after inoculation of ing, suggesting that one or more of the proteins synthe-
sized by d95 was ultimately cytotoxic. It is likely thatin1814 into mice, when replication at the site of inocula-
tion and in the ganglion is depressed but neuronal la- ICP0 was involved in the inhibition of cellular functions
because the protein accumulated in intranuclear bodiestency is established efficiently (Steiner et al., 1990; Ecob-
Prince et al., 1993). In tissue culture cells and in animal in d95-infected cells (Wu et al., 1996).
In the studies reported here, we describe the produc-models, therefore, in1814 replicates poorly and is predis-
posed to latency. tion and properties of novel host range HSV-1 mutants
that were initially constructed to test whether overex-The protein ICP0 is not absolutely required for virus
replication but facilitates the efficient initiation of produc- pression of ICP0 can compensate for the absence of
VP16 function in the context of virus infection, as pre-tive replication when cells are infected at low m.o.i. ICP0
stimulates gene expression from all promoters tested to dicted from studies based on the plasmid transfection
approach (Cai and Schaffer, 1992; Chen and Silverstein,date in plasmid cotransfection assays, including those
controlling HSV-1 IE, early and late HSV-1 genes (Everett, 1992). The ICP0 promoter of in1814 was replaced with
the strong LTR promoter of Moloney murine leukemia1984; O’Hare and Hayward, 1985; Cai and Schaffer, 1992;
Chen and Silverstein, 1992). These findings suggest a virus (Momulv) and the resulting virus, in1820, was found
to replicate efficiently in BHK cells but to behave in otherrole for ICP0 in activating all classes of gene expression
during infection, and in addition the protein may be im- cell types as if it lacks ICP0. This property was used for
the construction and efficient propagation of additionalportant in reactivation of HSV from latency by switching
on viral genes, including IE genes, in the absence of mutants that are conditionally deficient in VP16, ICP0,
and ICP4 function and thus fail to produce the three majorVP16 (Cai et al., 1993; O’Rourke and O’Hare, 1993). De-
creased expression of ICP0 is a major factor determining HSV-1 transactivators. These viruses, the most impaired
HSV-1 recombinants in terms of activation of gene ex-the phenotype of in1814, since HSV-1 mutants lacking
functional ICP0 show a restriction similar to that of in1814 pression yet produced, can be used to direct the expres-
sion of foreign genes without killing the host cell.in tissue culture cells (Stow and Stow, 1986; Sacks et
al., 1987; Everett, 1989), and transfection of a plasmid
that expresses ICP0 partially complements the replica- MATERIALS AND METHODS
tion defect of in1814 (Ace et al., 1989). Furthermore,
Plasmids
in1814 genomes which do not replicate can be seques-
tered in cells and recovered days later by superinfection Plasmid pGX164 is the XhoC fragment from the HSV-
1 strain 17 temperature-sensitive mutant tsK, which hasof cultures with HSV-1, but only if the superinfecting virus
expresses functional ICP0 (Harris and Preston, 1991). a mutation in the ICP4 coding sequences (Davison et
al., 1984). Plasmids pMC1, encoding VP16, and pMJ101,The possibility of using HSV as a vector for gene ther-
apy is currently the focus of many studies, since it may be containing Escherichia coli lacZ controlled by the human
cytomegalovirus (HCMV) major IE promoter, have beenpossible to utilize the ability of HSV to establish latency
to achieve retention of the viral genome in neurological described previously (Campbell et al., 1984; Jamieson et
al., 1995). To replace the ICP0 promoter with the Momulvtissues, and to use appropriate promoters to direct the
long-term expression of foreign gene products and LTR promoter, the starting plasmid was pJR3, which en-
codes ICP0 (Everett, 1984). Plasmid pJR3 was cleavedthereby derive therapeutic benefit (Glorioso et al., 1992,
1995; Geller, 1993; Efstathiou and Minson, 1995). A major with NcoI and SstI to remove the 966-bp ICP0 promoter
and regulatory region, and a double-stranded oligonucle-concern, however, is the known cytotoxicity of HSV. This
problem has been investigated by Johnson and cowork- otide (5*-CATGGGGGTCGTATGCGATATCGGACCTAT-
CGATGGTCCAAGCGCTTGGCACAGATCTTCCGAGCTers, who have demonstrated that the synthesis of IE pro-
teins, rather than the presence of virus structural pro- on one strand, with 4-bp 5*- and 3*-extensions) intro-
duced between the two sites. A 1.5-kbp SstI/RsaI frag-teins, is the main cause of cell killing (Johnson et al.,
1992; 1994). Their conclusions are partially based on the ment from BamHI k (representing sequences upstream
of the ICP0 promoter) was cloned between the adjacentanalysis of a derivative of in1814 which is additionally
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SstI and EcoRI sites of pJR3, to extend the region up- nant homozygous for the Momulv LTR was isolated as
described above, except that virus was propagated atstream of the ICP0 coding sequences. The 760-bp BamHI
fragment from pM1SP6 (Lang et al., 1983), containing the 317, to yield in1820K. ScaI-cleaved pMJ101 was cotrans-
fected with DNA from in1814K or in1820K and selectionMomulv LTR promoter, was cloned into the BglII site
introduced by the oligonucleotide (underlined), and a for the absence of thymidine kinase (TK), followed by
Southern transfer and hybridization, was carried out asplasmid with the Momulv promoter in the orientation to
direct expression of ICP0 was isolated, purified, and described previously (Jamieson et al., 1995). These ma-
nipulations produced in1894 (from in1814K) and in1332named pMo1. This plasmid was modified by removal of
the 250 bp of mink DNA upstream of the Momulv LTR, (from in1820K). Mutant tsK/MJ101 was similarly con-
structed from tsK. Mutant in1322 was also produced byto produce pMo2. Plasmid pMJ88 was constructed by
cleavage of pMJ101 with HindIII and XhoI and insertion of selection for TK0 viruses, after cotransfection of cells
with in1820K DNA and ScaI-cleaved pMJ88. Rescue ofa HindIII/SalI fragment from a modified pMC1NeoPoly(A)
(Nicholl and Preston, 1996), to place the neomycin phos- the VP16 mutation of in1332 was carried out by cotrans-
fection of in1332 DNA with pMC1, as described above,photransferase (npt) coding sequences downstream
from the HCMV IE promoter. to yield in1302. Mutants were routinely tested for respon-
siveness to hexamethylene bisacetamide (HMBA), to en-
sure that the VP16 mutation was present (McFarlane etViruses
al., 1992) and for plaque formation at 38.57 in the case of
ts mutants. Plaques were usually undetectable at 38.57,Mutant in1814 and the rescued ‘‘revertant’’ 1814R have
been described previously (Ace et al., 1989). In1820 was indicating that the proportion of revertants was less than
1 in 106. Particle concentrations were determined byconstructed by cotransfecting BHK cells with in1814
DNA, together with HindIII-cleaved pMo1. DNA from electron microscopy as described previously (Ace et al.,
1989).plaque isolates was digested with XbaI and BstEII, sub-
jected to agarose gel electrophoresis and Southern
transfer, and screened by hybridization with a 4.5-kbp Cells
BstEII fragment of pMo1 covering the site of insertion.
BHK-21 C13 cells were used for propagation of virusIsolates yielding bands of 3.2 and 1.3 kbp, due to the
stocks, with the addition of HMBA for the first 24– 48 hrintroduction of an XbaI site present in the Momulv pro-
postinfection where appropriate. HFL cells were Flowmoter, were plaque purified and retested by hybridiza-
2002 (Flow laboratories). Vero and HeLa cells were ob-tion. An isolate containing no parental 4.7-kbp fragment
tained from Flow laboratories. Mewo cells, derived fromwas named in1820. Mutant in1820B was isolated in the
a human melanoma, were provided by Dr A. Davisonsame way from an independent transfection, while mu-
(MRC Virology Unit, Glasgow), and Rat-1 cells were a gifttant in1820C was prepared in the same way except that
of A. Ingram (Glasgow University Virology Department).pMo2 was used instead of pMo1. The VP16 mutation of
Vero cell lines resistant to G418 were prepared afterin1820 was rescued by cotransfection of pMC1 with
transfection with pMJ88, as described previously (Nichollin1820 DNA and purification of viruses containing an
and Preston, 1996).intact BamHI f fragment, as determined by cleavage of
DNA with BamHI and hybridization to radiolabeled pMC1.
Cytotoxicity assayA homogeneous isolate was named in1825. The Momulv
insertion of in1825 was rescued by cotransfection of Confluent Vero cell monolayers on 35-mm-diameter
in1825 DNA with DraI-cleaved pGX152 (the cloned EcoRI plates were infected with 5 PFU of mutant viruses per
b fragment) into BHK cells and subsequent plaque purifi- cell, or mock infected, and incubated at 38.57 for 24 hr.
cation on HFL cells. Cleavage with XbaI plus BstEII fol- Plates were then trypsinized and cells suspended in 1
lowed by Southern transfer and hybridization using radio- ml of culture medium. Ten-fold serial dilutions were made
labeled 4.5-kbp BstEII fragment from pMo1 as probe was and added to 35-mm-diameter plates, in a total volume
carried out as described above, this time screening for of 2 ml. Cells were incubated at 38.57 for 6 days, with a
the presence of a 4.7-kbp fragment. A homogeneous iso- change of growth medium after 3 days, treated with
late was purified and named 1825R. Mutant in1814K was Giemsa stain, and colonies counted.
produced by cotransfection of in1814 DNA with XhoI-
cleaved pGX164 and subsequent screening for tempera- Histochemical staining for b-galactosidase
ture sensitivity on BHK cells. Two isolates were plaque
purified twice and tested for recombination with tsK (re- Monolayers of Vero or HeLa cells on 35-mm-diameter
plates were infected with 5 PFU of in1332 per cell, orsults not shown). Neither isolate recombined with tsK to
produce nontemperature sensitive virus, and one was mock infected, and incubated at 38.57. At 6 hr postinfec-
tion, monolayers were fixed and stained for the presenceselected for further analysis. DNA from in1814K was co-
transfected with HindIII-cleaved pMo1 and a recombi- of b-galactosidase using 5-bromo-4-chloro-3-indolyl b-D-
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TABLE 1 yield a virus unable to establish latency in tissue culture
or animals. Cotransfection of in1814 DNA with pMo1,Viruses Used in the Study
in which the Momulv LTR promoter replaces the ICP0
Name VP16 ICP0 promoter ICP4 Inserta promoter, resulted in a high proportion (23/48) of virus
plaque isolates containing the substitution, and a second
in1814 0 0b wt round of plaque purification on BHK cells readily pro-
1814R / 0 wt duced a pure homozygous preparation, in1820. The easein1820 0 Moc wt
with which in1820 was isolated suggested a selectivein1825 / Mo wt
1825R / 0 wt advantage for the new mutant. The VP16 insertion of
in1820B 0 Mo wt in1820 was rescued by cotransfection with pMC1 to yield
in1820C 0 Mo wt in1825, structurally wild-type HSV-1 except for the ICP0
in1814K 0 0 ts
promoter exchange, and the Momulv insertion was thenin1894 0 0 ts HCMV-lacZ
removed by recombination with pGX152 to give 1825R,in1820K 0 Mo ts
in1332 0 Mo ts HCMV-lacZ in which all introduced mutations were rescued.
in1322 0 Mo ts HCMV-npt Viruses were titrated on BHK or HFL cells in the pres-
in1302 / Mo ts HCMV-lacZ ence or absence of HMBA, which complements the repli-
tsK/MJ101 / 0 ts HCMV-lacZ
cation defect of in1814 by stimulating IE gene expression
(McFarlane et al., 1992) (Table 2). To provide a compari-a Insertions at the TK locus.
b Normal ICP0 promoter. son between virus mutants, particle concentrations were
c Momulv LTR promoter. determined and the particle:PFU ratios on the two cell
lines calculated. Thus, high ratios indicate impairment in
the initiation of productive infection. As expected, 1814Rgalactoside (X-gal) as substrate, as described previously
preparations contained between 10 and 47 particles per(Jamieson et al., 1995).
PFU on BHK and HFL cells. Mutant in1814 gave values
at least 100-fold higher than those of 1814R, with greaterConversion to G418 resistance
impairment on HFL than BHK cells (Ace et al., 1989). In
Confluent Vero cell monolayers on 35-mm-diameter the presence of HMBA, in1814 gave a ratio 2.5 (BHK)- or
plates were infected with 1 or 5 PFU of in1322 per cell, 5.2 (HFL)-fold greater than that of 1814R, in agreement
or mock infected, and incubated at 38.57 with 800 mg of with previous studies which showed that complementa-
G418 (Geneticin, from Life Technologies, Paisley, Scot- tion by HMBA underestimates the number of potentially
land) per milliliter. At 6 hr postinfection, cells were tryp- active particles by a factor of approximately 3 (McFarlane
sinized and 35-mm-diameter plates reseeded with one- et al., 1992; Jamieson et al., 1995). Mutant in1820 exhib-
tenth of the cell suspension. Cells were incubated at ited a different pattern: on BHK cells it initiated infection
38.57 with 500 mg/ml G418, and at various times mono- 10-fold more efficiently than in1814, and with HMBA it
layers were trypsinized and cells counted using a count- formed plaques 3- to 6-fold less efficiently than 1814R.
ing chamber. The mean value from four independent de- On HFL cells, however, in1820 was more restricted than
terminations was calculated. in1814, behaving as if deficient in both VP16 and ICP0.
Plaque formation on HFL cells was stimulated 100-fold
Npt assays
by HMBA but complementation was not complete, as
Cells were washed with phosphate-buffered saline
and lysed with a buffer consisting of 10 mM Tris – HCl, 2 TABLE 2
mM MgCl2, 10 mM NaCl, 0.5% (v/v) Nonidet P-40, pH 7.5,
Particles:PFU Characteristics of Virus Mutantsand cytoplasmic extracts made as described previously
(Preston, 1979a). Npt activity was assayed by incorpora- Particle:pfu ratioa
tion of 32P into neomycin, as described previously (Palmer
Virus HMBA BHK HFLet al., 1993).
1814R 0 19 (11–47)8 28 (10– 38)4RESULTS
in1814 / 48 (15–120)10 114 (31– 290)5
in1814 0 4,700 (1,500 –10,000)9 96,000 (4,400 – 440,000)7Substitution of the in1814 ICP0 promoter
in1820 / 120 (40–182)5 5,700 (3,000 – 8,600)4
in1820 0 314 (150–562)8 380,000 (15,000– 900,000)7The experiments described here are based on the con-
in1825 / 11 (10–13)3 6,200 (1,200 – 15,000)4struction and analysis of HSV-1 mutants, and the salient
in1825 0 31 (17–72)5 50,000 (5,800 – 90,000)5features of the viruses used are summarized in Table 1.
1825R 0 7 (4–11)4 13 (8– 16)3
Initially, it was intended to investigate whether substitu-
tion of the ICP0 promoter with a strong ‘‘enhancer’’ ele- a The range of values is given in parentheses and the number of
determinations as a superscript.ment compensated for the absence of VP16 function, to
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TABLE 3
Efficiency of Plaque Formation on Different Cell Types
Relative efficiency of plaque formation
Virus HMBAa BHK HFL HeLa MeWo Vero Rat-1
1814R 0 100b 63 26 125 197 20
in1814 / 100b 56 38 100 60 15
in1814 0 1.5 0.064 0.43 0.10 1.6 0.006
in1820 / 100b 1.2 14 6.7 2.1 7.7
in1820 0 58 0.016 0.36 0.067 0.15 0.015
a HMBA was added at 3 mM throughout the titration for BHK cells, at 5 mM throughout for HFL, HeLa, MeWo, and Rat-1, and at 3 mM between
1 and 6 hr after infection for Vero cells.
b The titer on BHK cells (/HMBA for in1814 and in1820) was defined as 100, and the titers on other cell types were compared to this value for
a given virus.
shown by the high particle:PFU ratio of 5,700 (200-fold activation by ICP0 was improved in BHK but impaired in
HFL cells, was considered. The ICP0 coding sequencesgreater than that of 1814R). Mutant in1825 initiated infec-
tion in BHK cells essentially as well as 1814R but was were cloned from in1825 DNA as a 5345-bp NcoI/PstI
fragment and used to construct pMJ94, which is identicalrestricted in HFL cells, and HMBA increased the effi-
ciency of plaque formation only by 5-fold, as shown pre- to pJR3 (apart from the absence of a 200-bp PstI fragment
downstream of the ICP0 sequences). In cotransfectionviously (McFarlane et al., 1992). The multiple rescuant
1825R initiated infection at least as efficiently as 1814R assays, pJR3 and pMJ94 stimulated b-galactosidase ex-
pression from pCMVb-gal (lacZ controlled by the HCMVin both cell types. Substitution of the Momulv LTR for the
ICP0 promoter therefore produced a host range mutant, major IE promoter) to the same extent (approximately
fourfold) in both BHK and HFL cells (results not shown).in1820, which is less restricted than in1814 for replication
in BHK cells but more restricted in HFL cells. Therefore, the host range phenotypes of in1820 and
in1825 are not due to a mutation in the ICP0 codingTo determine which phenotype is observed generally,
a range of tissue culture cells was infected with 1814R, sequences.
Following the rationale for the construction of in1820,in1814, or in1820 (Table 3). Although variation was found
in the relative plating efficiencies of in1814 and in1820 it is likely that alterations to the expression of ICP0 ac-
count for the phenotype of the mutant. This conclusionbetween cell types, as noted previously (Ace et al., 1989),
the titer of in1820 without HMBA did not approach the is supported by two observations: first, reversion of the
mutations of in1820 results in a virus (1825R) that isfully complemented value (BHK cells with HMBA) in any
of the cultures examined except BHK. Mutant in1820 was indistinguishable from 1814R and, second, the parti-
cle:PFU ratio of in1825 in restricted cells is within thetherefore restricted for initiation of replication in all of
range of that reported for the ICP0 null mutant dl1403the additional cell types tested including the rodent line
(Stow and Stow, 1986; Everett, 1989). Recent studies,rat-1. The presence of HMBA only partially comple-
however, have shown the existence of transcriptsmented plaque formation by in1820, and again the de-
gree of enhancement varied between cell types.
The observation that 1825R initiates infection of HFL TABLE 4
cells as efficiently as 1814R suggests that the promoter
Comparison of in1820, in1820B, and in1820Cexchange, rather than other fortuitous mutations, is re-
sponsible for the unusual phenotype of in1820. To con- Relative efficiency
firm that this is the case, a second isolate, in1820B, was of plaque formation
made from in1814 in an independent cotransfection. In
Virus HMBA BHK HFLaddition, because the Momulv insert used to create
in1820 also contains 250 bp of mink genomic DNA up- in1820 / 100a 3.8
stream of the LTR (Lang et al., 1983), a virus lacking in1820 0 44 0.060
the mink portion, in1820C, was constructed. The new in1820B / 100a 3.0
in1820B 0 41 0.024mutants exhibited the same host range as in1820 (Table
in1820C / 100a 3.04), demonstrating that the Momulv LTR is responsible for
in1820C 0 32 0.024the novel phenotype of in1820.
In addition, the unlikely possibility that a mutation had a The titer on BHK cells, with HMBA, was defined as 100 and other
titers for a given virus were compared to this value.arisen during the construction of pMo1, such that trans-
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TABLE 5 mutant ts1201 (Preston et al., 1983), and plaque formation
at 38.57 determined. Mixed infections containing 1.25 1Mutants in1825 and dl1403 Do Not Cross Complementa
105 particles each of dl1403 and in1825 gave a number
Virus Particles Virus Particles of plaques (59) approximately equal to the mean of that
1 (1105) 2 (1105) Plaquesb exhibited by 2.5 1 105 particles of the viruses individually
(40 and 73) and, similarly, mixing 2.5 1 105 particles of
dl1403 1.25 14 (9– 16) each mutant gave a value (113) essentially equivalent todl1403 2.5 40 (34– 48)
the mean of 5 1 105 particles of dl1403 and in1825 alonedl1403 5.0 92 (86– 102)
in1825 1.25 36 (33– 40) (92 and 120). Control experiments showed that comple-
in1825 2.5 73 (64– 84) mentation of dl1403 could be detected even with only
in1825 5.0 120 (107– 138) 2.51 104 particles of tsK or ts1201, both of which produce
tsK 2.5 0
ICP0. This experiment demonstrates that in1825 did notts1201 2.5 0
produce amounts of ICP0 sufficient to complementdl1403 1.25 in1825 1.25 59 (46– 74)
dl1403 2.5 in1825 2.5 113 (104– 116) dl1403, and hence that the lack of functionally adequate
dl1403 2.5 tsKc 0.25 76 (65– 83) levels of ICP0 is the cause of the restricted initiation of
dl1403 2.5 tsK 2.5 300 replication in HFL cells, and presumably other cell types
dl1403 2.5 ts1201 0.25 106 (99– 109)
apart from BHK.dl1403 2.5 ts1201 2.5 300
in1825 2.5 tsK 0.25 120 (107– 138)
Construction of HSV-1 mutants with multiple defectsin1825 2.5 tsK 2.5 300
in1825 2.5 ts1201 0.25 145 (143– 146) in IE gene function
in1825 2.5 ts1201 2.5 300
In nearly all cell types tested in1820 is effectively de-tsK 0.25 ts1201 2.5 124 (112– 135)
tsK 2.5 ts1201 0.25 140 (139– 140) void of VP16 and ICP0 activity, yet it can readily be propa-
tsK 2.5 ts1201 2.5 300 gated in BHK cells in the presence of HMBA since under
these conditions it replicates almost as efficiently asa Monolayers of 8 1 105 HFL cells were coninfected and plaques
wild-type HSV-1. When cultures are infected under condi-formed at 38.57 were scored.
tions in which individual cells receive 1 particle of in1814b The range of values from 3 to 6 determinations is given in parenthe-
ses. or in1820, most cells survive infection and harbor the
c The tsK and ts1201 preparations had particle:PFU ratios of 8.8 and virus in a quiescent state which resembles latency in
7.9, respectively (317 titers). This information can be used to estimate some respects (Harris and Preston, 1991; Jamieson et al.,that the dl1403 and in1825 preparations contained 19 and 16 particles
1995). At higher m.o.i., however, cell destruction occurs,per complementing unit, respectively (for example, 0.25 1 105 particles
limiting the value of these mutants as potential vectors.of tsK represents 2.8 1 103 PFU or 1 cell in 285 infected with a PFU;
coinfection with 2.5 1 105 particles of dl1403 gave an increase of 36 Since expression of IE proteins is mainly responsible for
in the dl1403 titer, thus 2.5 1 105 dl1403 particles represents 1 1 104 cell killing (Johnson et al., 1994), we constructed a virus
[36 1 285] complementing units. The analogous calculation for dl1403
which is conditionally deficient in VP16, ICP0, and ICP4and ts1201 gives 1.6 1 104 complementing units from 2.5 1 105 PFU
functions. Mutant in1814K was first produced, and thisdl1403 particles). Using these values, it can be calculated that cultures
was used as a template for the formation of in1820K. Inwhich received 2 1 105 PFU each of dl1403 and in1825 contained 230
cells dually infected with a complementing unit of each virus. In the BHK cells at 317 in the presence of HMBA, in1820K can
control experiment, coinfection with 2.5 1 105 particles of tsK and 0.25 be propagated essentially as wild-type HSV-1 since none1 105 particles of ts1201 was calculated to result in 56 cells receiving
of the three mutations are operative, but at 38.57 in HFLa PFU of each virus, thus the observed value of 124 plaques demon-
(or other cell types) without HMBA the virus is effectivelystrates that complementation was as efficient as predicted.
negative for VP16, ICP0, and ICP4 functions. This is the
most restricted HSV mutant in terms of transcription acti-
(named L/STs) that are transcribed divergently from the
vators available to date, and in the following sections the
mRNA encoding ICP0, and the presumed promoter for
properties of this novel mutant, with particular emphasis
these transcripts was also removed in the construction
on its possible value as a prototype vector, are described.
of in1820 (Yeh and Schaffer, 1993; Bohensky et al., 1995).
To confirm that the reduced efficiency of plaque forma- Cytotoxicity
tion in HFL cells is due to the effective absence of ICP0,
complementation between in1825 and the ICP0 deletion It was possible to infect a number of cell types with 5
PFU of in1820K per cell without visible cpe after 24 hr atmutant dl1403 was investigated (Table 5). This experi-
ment is less sensitive than a classical complementation 38.57, whereas in1814K under the same conditions
caused alterations to cell morphology, particularlyanalysis because the deletion of ICP0 is not a ‘‘tight’’
mutation and thus there is a background of replication rounding of cells (results not shown). To apply a more
stringent evaluation of cytotoxicity, Vero cultures werefrom those viruses which enter the lytic cycle, even at
low m.o.i. Monolayers of HFL cells were coinfected with infected with 5 PFU of various viruses per cell, incubated
at 38.57 for 24 hr, trypsinized, serially diluted and replatedvarious pairings of mutants, including tsK and the ICP24
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TABLE 6 be used to produce significant functional levels of foreign
proteins in infected cells, the npt gene controlled by theCytotoxicity of Virus Mutantsa
HCMV IE promoter was cloned into the TK locus of
Virus Plating efficiency (%)b in1820K, to yield in1322. Vero cell monolayers were in-
fected with in1322 in the presence of G418, incubated
in1332 91 (77 –100) at 38.57 for 6 hr and then trypsinized and plated at 38.57
in1894 13 (8– 17) with G418 present, at a split ratio of 1:10. Infected cellin1302 3 (1– 5)
cultures replicated rapidly, whereas mock-infected cul-tsK/MJ101 0.4 (0.1 – 0.6)
tures did not (Fig. 2A). At 2 days after subculture, mono-
a Vero cell monolayers were infected with 5 PFU of various viruses layers infected with 5 PFU per cell were largely normal
per cell and incubated at 38.57 for 24 hr. Monolayers were trypsinized, in appearance (Fig. 2D), while mock-infected cells dis-
serially diluted, and plated out. Colonies formed after 6 days were
played characteristic alterations due to killing by G418counted and expressed as a percentage of the number derived from
(Fig. 2B). Cells derived from infected cultures remainedmock-infected cells. The efficiency of plating of mock-infected cells
was approximately 100%. predominantly morphologically normal for a further 2
b The mean values from three independent experiments are pre- days, although increasing numbers cells showing G418-
sented, with the ranges given in parentheses. induced cytopathology became apparent. Similar results
were obtained when the initial m.o.i. was 1 PFU of in1322
per cell (Fig. 2C), although greater cell degeneration wasat 38.57. Colonies were counted after 6 days (Table 6).
observed at 3 days after subculture. Therefore, amountsMutant in1332 only marginally reduced plating efficiency
of npt sufficient to protect cells from G418 toxicity for atat m.o.i. of 5 PFU per cell, demonstrating that the majority
least 2 days were produced after infection of Vero cul-of cells infected in this way survived infection. Cell viabil-
tures with 5 PFU of in1322 per cell.ity of approximately 100% was also observed when sub-
The degree and duration of protection from the toxicculture was carried out at 6 hr after infection of Vero
effects of G418 after infection with in1322 were some-cells, and when HeLa or human 143TK0 cells were in-
what unexpected, for two reasons. First, when quiescentfected with 5 PFU of in1332 for 24 hr (results not shown).
in tissue culture cells in1814-based mutants do not repli-Infection with mutant in1894 reduced colony formation
cate their genomes as the host cell divides (Russell andby a factor of approximately 7, demonstrating that ICP0
Preston, 1986; Jamieson et al., 1995), thus many of thefunction contributed to cytotoxicity. Mutant tsK/MJ101
cells in cultures that had reached confluence may notkilled all cells estimated to receive at least 1 PFU of
have contained a viral genome. Second, expression ofvirus. The mutant in1302, in which the VP16 mutation
lacZ-specific RNA from the HCMV IE promoter is tran-was rescued from in1332, regained significant cytotoxic-
sient in cells infected with in1332 (C. M. Preston, unpub-ity, demonstrating that the absence of VP16 function and
lished results), thus prolonged expression of npt fromconsequent reduction in IE gene expression was a cru-
the in1322 genome would not have been anticipated.cial factor in the reduced cytotoxicity of in1820K based
The production of npt was therefore assayed in culturesmutants. This observation formally rules out the possibil-
infected with in1322, and as a control the enzyme levelsity that other fortuitous mutations in in1814 or its deriva-
in Vero cells stably transformed to G418 resistance bytives are responsible for the reduced cell killing by
pMJ88 was also determined (Fig. 3). The major period ofin1820K (or 14DH3, described by Johnson et al., 1994).
npt synthesis occurred during the initial stages of infec-
tion but enzyme levels remained above those in the trans-Gene expression
formed cell line until 3 days postinfection. Therefore, in-
fection with in1322 results in the retention of functionallyTo determine the extent to which vectors based on
in1820K express foreign genes, reporter sequences were significant levels of npt for up to 3 days postinfection,
explaining the successful short term alteration of cellcloned under the control of the HCMV major IE promoter
and subsequently recombined into the viral genome. phenotype shown in Fig. 2.
Vero and HeLa monolayers were infected with 5 PFU per
cell of in1332, which contains the lacZ gene controlled DISCUSSION
by the HCMV IE promoter, and incubated at 38.57 for 6
hr. Upon histochemical staining, b-galactosidase was In making an apparently straightforward change to the
in1814 genome, we have produced a virus mutant withpresent in almost all cells in the culture, generally at low
but detectable levels although expression was heteroge- an unexpectedly complex host range phenotype: in BHK
cells, despite the lack of VP16 function, in1820 initiatedneous in that some cells expressed the enzyme more
efficiently than the majority (Fig. 1). Therefore, it is possi- replication more efficiently than in1814, whereas in all
other cell types tested in1820 was more impaired thanble to establish conditions in which effectively all cells
remain viable and express b-galactosidase. in1814. Our results demonstrate that the restricted phe-
notypes of in1820 (compared with in1814) and in1825To investigate whether in1820K-based mutants could
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FIG. 1. Production of b-galactosidase. Vero (A and B) or HeLa (C and D) monolayers were mock infected (A and C) or infected with 5 PFU of
in1332 per cell (B and D) and stained for the presence of b-galactosidase after incubation at 38.57 for 6 hr. No positive cells were detectable on
mock-infected cultures, whereas nearly all cells expressed b-galactosidase at low levels in infected cultures. Magnification, 1200.
(compared with 1814R) are due to the absence of func- converted to its quiescent form, in which expression of
viral genes does not occur (Jamieson et al., 1995). Thetional levels of ICP0 and thus failure to activate gene
expression efficiently. This conclusion is based on three results demonstrate that the effect of alteration of the
regulation of an HSV-1 gene can be as dramatic as thatlines of evidence: first, rescue of the ICP0 promoter ex-
change overcomes the restriction of in1825; second, of deleting the gene altogether, thus it may be possible
to use this concept to devise new ways of obtaining hostin1825 has the same degree of impairment as dl1403,
based on their similar particle:PFU characteristics; and, or cell-specific expression of foreign genes cloned into
HSV-1 vectors.third, dl1403 and in1825 do not cross complement. It is
clear that the surprising phenotype of in1820 is due to In an experiment to determine the effect of the ICP0
promoter substitution on virulence after inoculation intothe Momulv insertion since mutants with the same prop-
erties have essentially been constructed independently mice via the footpad, in1825 was found to produce ap-
proximately 10-fold fewer neurons positive for HSV-1 an-on three additional occasions (in the production of
in1820B, in1820C, and in1820K). Furthermore, the possi- tigens than 1825R at 5 days after inoculation, and a simi-
larly reduced number of neurons positive for the majorbility of a host range change in the ICP0 protein was
excluded by the observation that the gene cloned from latency-associated transcript during latency (C. M. Pres-
ton and M. S. Ecob-Prince, unpublished results). The re-in1825 activated gene expression normally. The Momulv
LTR is not regulated as a viral IE promoter during infec- stricted phenotype exhibited in most tissue culture cells
was therefore also observed in mice (even though thetion of HFL cells at high m.o.i. (Jamieson et al., 1995),
thus it is likely that insufficient amounts of IE proteins, Momulv LTR is considered to be adapted for expression
in rodent cells).especially ICP0 itself, are produced to activate the Mo-
mulv promoter and consequently the in1820 genome is From the nature of the insertion used to construct
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FIG. 2. Production of npt. Vero cells were mock infected or infected with 1 or 5 PFU of in1322 per cell. After incubation at 38.57 for 6 hr in the
presence of G418, monolayers were trypsinized and cells replated at one-tenth the original density, with G418 present. Cells were counted at
various times after subculture (A), and photographs were taken of mock-infected cultures (B) or cultures infected with 1 (C) or 5 (D) PFU of in1322
per cell. Magnification, 1200.
in1820 and the logic of the experimental approach, it is would be necessary to compare ICP0-specific RNA levels
under conditions in which the host range phenotype islikely that the improved replication in BHK cells of this
mutant, compared with that of in1814, is due to greater observed, that is, at very early times after infection with
in1814 and in1820 at low m.o.i. This is difficult, however,synthesis of ICP0 and hence compensation for the lack
of IE gene activation by VP16. This hypothesis predicts for two reasons. First, once ICP4 has been produced,
powerful activation of gene expression ensues (due tothat the Momulv promoter is more active than the ICP0
promoter in BHK cells but that the converse is true in ICP4 and the consequent increase in the level of ICP0)
and thus the relative amounts of ICP0-specific mRNA inother cell types. To demonstrate that this is the case, it
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even the small amounts of ICP0 produced in the absence
of VP16 function contribute to cytotoxicity. In tests in
which HFL cells were infected and the increase in cell
numbers after 3 days was measured, infection with
in1814K-derived viruses gave results similar to those of
Johnson et al. (1994) using the same approach, whereas
in1820K was much less cytotoxic (R. Mabbs and C. M.
Preston, unpublished results). We consider, however,
that determination of plating efficiency is a more stringent
criterion for the estimation of cell viability, and that the
ability of at least 90% of cells infected with 5 PFU of
in1332 to reseed demonstrates that construction of the
new mutants has significantly overcome the problem of
cytotoxicity, at least in tissue culture cells. The recently
described mutant d95 (Wu et al., 1996) is in many ways
complementary to in1820K, since VP16 and ICP0 func-
tions are retained but ICP4, ICP22, and ICP27 are re-FIG. 3. Production of npt. Vero cell monolayers were infected with
5 PFU of in1322 per cell and maintained at 38.57. At various times moved. Consequently, cells infected with d95 express
duplicate monlayers were harvested and assayed for npt activity (s). ICP0 and other viral proteins for 3 days, but cease DNA
In addition, extracts from monolayers of Vero cells transformed to G418 synthesis and are killed, presumably due to the accumu-
resistance by pMJ88 were assayed (l).
lation of ICP0. Our results confirm that ICP0 is cytotoxic
even at the low levels made in the absence of VP16
function (i.e., by the in1814K derivative in1894), and em-BHK and HFL cells would simply reflect the number of
cells destined to enter lytic replication rather than the phasize that reduction of IE protein synthesis is important
for cell survival.initial utilization of the Momulv and ICP0 promoters by
cellular transcription factors. Second, attempts to mea- The demonstration that in1322 can convert an entire
cell population to G418 resistance constitutes ‘‘proof ofsure gene expression under IE conditions are con-
founded by the observation that inhibition of protein syn- principle’’ that HSV vectors can transfer foreign proteins
to tissue culture cells in quantities sufficient to confer athesis itself influences promoter activity (C. M. Preston,
unpublished observations). Other explanations are possi- phenotypic alteration without significant toxicity from the
vector itself. This property of the in1820K mutants mayble for the host range phenotype of in1820. There may
be a factor in BHK cells which mimics the activity of be useful in basic studies designed to analyze relatively
short term (up to 48 hr) effects of gene products. TheICP0, as exists in U2OS cells (Yao and Schaffer, 1995),
although if this is the case the putative factor must act ability of HSV to infect a wide variety of cell types, cou-
pled with the absence of cytotoxicity, provides advan-preferentially on viruses with the Momulv promoter inser-
tion because in1825 forms plaques on BHK cells much tages over many other virus vectors, and the possibility
of infecting all cells in a culture gives the potential formore efficiently than dl1403 (Stow and Stow, 1986). It is
possible that alterations to the synthesis of L/STs tran- more efficient gene transfer than can be achieved by
transfection and other chemical methods. In addition, inscripts and resultant effects on the synthesis of the pre-
dicted product, the ORF P protein, influence virus replica- 1820K may be useful as a noncytotoxic helper for the
production of HSV-based amplicons. For application intion in BHK cells in an undetermined way (Yeh and Schaf-
fer, 1993; Bohensky et al., 1995; Lagunoff and Roizman, human gene therapy, it will be necessary to couple long-
term expression of therapeutic genes with the advan-1995). It is also noteworthy that the Momulv LTR contains
sequences that confer long term expression to the LAT tages presented by mutants multiply impaired for expres-
sion of IE products.promoter during latency in mice (Lokensgard et al., 1994):
perhaps the same property is important for prolonging
production of ICP0 in BHK cells. ACKNOWLEDGMENTS
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